2021
DOI: 10.1007/s00424-021-02518-1
|View full text |Cite
|
Sign up to set email alerts
|

A novel mutation in KCNH2 yields loss-of-function of hERG potassium channel in long QT syndrome 2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 38 publications
0
2
0
Order By: Relevance
“…In silico analysis predicts the variant to be probably deleterious to the protein structure and/or function. An alternative missense variant in the same residue (p.(Ser631Ala)) has been reported in the Human Gene Mutation Database linked with a long QT syndrome [ 19 ], supporting the functional importance of this residue. Further functional analyses would be warranted to elucidate the particular consequences of the alteration.…”
Section: Discussionmentioning
confidence: 91%
See 1 more Smart Citation
“…In silico analysis predicts the variant to be probably deleterious to the protein structure and/or function. An alternative missense variant in the same residue (p.(Ser631Ala)) has been reported in the Human Gene Mutation Database linked with a long QT syndrome [ 19 ], supporting the functional importance of this residue. Further functional analyses would be warranted to elucidate the particular consequences of the alteration.…”
Section: Discussionmentioning
confidence: 91%
“…Congenital LQTS (ORPHA:768) is a clinical disorder of genetic origin characterized by delayed repolarisation of the myocardium, electrocardiographic QT prolongation, and increased risk of syncope, seizures, and SCD caused by polymorphic ventricular tachycardia, known as Torsades des Pointes (TdP) [3]. To date, pathogenic variants associated with LQTS have been identified in 19 autosomal-recessive pattern (TRDN), and two following both autosomal-dominant andrecessive patterns (KCNQ1 and KCNE1) [4,5]. LQT1, LQT2, and LQT3 genotypes comprise more than 95% of the patients with genotype-positive LQTS and approximately 75% of all patients with LQTS [6].…”
Section: Introductionmentioning
confidence: 99%